Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
-Earnings: -$90.72 million in Q4 vs. -$21.39 million in the same period last year.
-EPS: -$1.07 in Q4 vs. -$0.28 in the same period last year.
-Analysts projected -$0.96 per share
-Revenue: $7.55 million in Q4 vs. $24.02 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com